Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
Hematologic Oncology Update
00:00
Patient Experience and Management of Side Effects
Exploring the experience of a patient receiving CD20 x CD3 bispecific antibodies and discussing the precautions, symptom management, and support system needed for treatment. Also, comparing different treatment approaches for lymphoma.
Transcript
Play full episode
